Dier Mardi (CIK 0001574591)

Latest company ownership

Shares held
66,695
Last filed at
Oct 17, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
27,966
Last filed at
Dec 3, 2025
Confidence Score
18.6
2025Q4
Confidence Score History
2025Q1 2025Q4
Shares held
23,500
Last filed at
Jun 18, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 2, 2025 Dec 3, 2025 MADRIGAL PHARMACEUTICALS, INC. CFO Sell 5.0 -4,173 -28.56% ✓ $2.4M
Mar 10, 2025 Mar 12, 2025 MADRIGAL PHARMACEUTICALS, INC. CFO Sell 41.3 -258 -2.41% ✓ $83.3K
Mar 3, 2025 Mar 5, 2025 MADRIGAL PHARMACEUTICALS, INC. CFO Sell 12.5 -1,961 -22.10% ✓ $637.2K
Oct 14, 2022 Oct 17, 2022 Ultragenyx Pharmaceutical Inc. CFO Sell 41.3 -1,629 -2.38% ✓ $65.4K
Oct 12, 2022 Oct 14, 2022 Ultragenyx Pharmaceutical Inc. CFO Sell 42.5 -3,484 -4.85% ✗ $133.2K
Mar 1, 2022 Mar 3, 2022 Ultragenyx Pharmaceutical Inc. CFO Sell 95.0 +13,046 33.66% ✓ $62.7K
Oct 12, 2021 Oct 14, 2021 Ultragenyx Pharmaceutical Inc. CFO Sell 22.5 -6,738 -14.81% ✓ $552.5K
Sep 29, 2020 Sep 29, 2020 Prelude Therapeutics Inc Director Buy 95.0 +10,000 100.00% ✗ $190K